Order Article Reprints

Werumeus Buning A, Hodiamont CJ, Lechner NM, Schokkin M, Elbers PWG, Juffermans NP, Mathôt RAA, de Jong MD, van Hest RM. Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection. Antibiotics. 2021; 10(6):612. https://doi.org/10.3390/antibiotics10060612

Werumeus Buning, Annabel, Caspar J. Hodiamont, Natalia M. Lechner, Margriet Schokkin, Paul W. G. Elbers, Nicole P. Juffermans, Ron A. A. Mathôt, Menno D. de Jong, and Reinier M. van Hest. 2021. "Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection" Antibiotics 10, no. 6: 612. https://doi.org/10.3390/antibiotics10060612

Werumeus Buning, A., Hodiamont, C. J., Lechner, N. M., Schokkin, M., Elbers, P. W. G., Juffermans, N. P., Mathôt, R. A. A., de Jong, M. D., & van Hest, R. M. (2021). Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection. Antibiotics, 10(6), 612. https://doi.org/10.3390/antibiotics10060612